At the same time S&P downgraded the health system’s long-term rating to “BBB-” from “BBB.”
The downgrade is a result of the company’s weaker than average liquidity relative to similarly rated peers and its weak operating performance.
“While we recognize WCHC has embarked on a growth strategy over the last several years that is strengthening its overall enterprise profile, it has coincided with a period of weaker than expected operating performance and cash flow metrics,” said S&P credit analyst Anne Cosgrove.
The outlook is stable, reflecting S&P’s expectation that the health system will see an improved operating performance in fiscal year 2018.
More articles on healthcare finance:
CMS’ proposed outpatient payment rule for 2019: 10 things to know
CMS terminates Idaho hospital’s Medicare contract
CHS sees net loss narrow to $110M, pursues $2B hospital divestiture plan
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
